Literature DB >> 29860704

Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?

Michael Joannidis1, Eric Hoste2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29860704     DOI： 10.1007/s00134-018-5223-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

1.  Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction.

Authors:  F Ryckwaert; P Colson; J Ribstein; G Boccara; G Guillon
Journal:  Br J Anaesth       Date:  2001-02       Impact factor: 9.166

Review 2.  [Life after Acute Kidney Injury : Long-term consequences and implications for clinical practice].

Authors:  S J Klein; A K Brandtner; M Peball; M Joannidis
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-09-05       Impact factor: 0.840

3.  Association between AKI and long-term renal and cardiovascular outcomes in United States veterans.

Authors:  Lakhmir S Chawla; Richard L Amdur; Andrew D Shaw; Charles Faselis; Carlos E Palant; Paul L Kimmel
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

4.  Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action.

Authors:  Jill T Norman; Ray Stidwill; Mervyn Singer; Leon G Fine
Journal:  Nephron Physiol       Date:  2003

5.  Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.

Authors:  Frank Wagner; Ruhi Yeter; Susanne Bisson; Henryk Siniawski; Roland Hetzer
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

6.  Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.

Authors:  Etienne Gayat; Alexa Hollinger; Alain Cariou; Nicolas Deye; Antoine Vieillard-Baron; Samir Jaber; Benjamin G Chousterman; Qin Lu; Pierre François Laterre; Xavier Monnet; Michael Darmon; Marc Leone; Bertrand Guidet; Romain Sonneville; Jean-Yves Lefrant; Marie-Céline Fournier; Matthieu Resche-Rigon; Alexandre Mebazaa; Matthieu Legrand
Journal:  Intensive Care Med       Date:  2018-05-15       Impact factor: 17.440

7.  Acute Kidney Injury Treated with Dialysis outside the Intensive Care Unit: A Retrospective Observational Single-Center Study.

Authors:  Hannelore Sprenger-Mähr; Emanuel Zitt; Karl Lhotta
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

Review 8.  Renal recovery after acute kidney injury.

Authors:  L G Forni; M Darmon; M Ostermann; H M Oudemans-van Straaten; V Pettilä; J R Prowle; M Schetz; M Joannidis
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

9.  Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.

Authors:  Melanie Meersch; Christoph Schmidt; Andreas Hoffmeier; Hugo Van Aken; Carola Wempe; Joachim Gerss; Alexander Zarbock
Journal:  Intensive Care Med       Date:  2017-01-21       Impact factor: 17.440

10.  ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study.

Authors:  Laurie A Tomlinson; Gary A Abel; Afzal N Chaudhry; Charles R Tomson; Ian B Wilkinson; Martin O Roland; Rupert A Payne
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240
View more
  2 in total

1.  A Process for the Design and Development of Novel Bone Morphogenetic Protein-7 (BMP-7) Mimetics With an Example: THR-184.

Authors:  William D Carlson; Peter C Keck; Dattatreyamurty Bosukonda; Frederic Roy Carlson
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

2.  Intravital imaging of hemodynamic glomerular effects of enalapril or/and empagliflozin in STZ-diabetic mice.

Authors:  Hannah Kroeger; Friederike Kessel; Jan Sradnick; Vladimir Todorov; Florian Gembardt; Christian Hugo
Journal:  Front Physiol       Date:  2022-09-12       Impact factor: 4.755
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.